Sodium/myo-inositol cotransporter 1 and myo-inositol are essential for osteogenesis and bone formation

Journal of Bone and Mineral Research

Volumn 26, Issue 3, 2011, Pages 582-590

  Dai, Zhijie ^a   Chung, Sookja K ^b   Miao, Dengshun ^c   Lau, Kam S ^a   Chan, Alfred W H ^a   Kung, Annie W C ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b Department of Medicine and Physiology ^*  (Hong Kong)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

bone formation; myo inositol; osteogenesis; Smit1

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; COTRANSPORTER; FIBROBLAST GROWTH FACTOR 4; INDUCIBLE NITRIC OXIDE SYNTHASE; INOSITOL; INOSITOL 1,4,5 TRISPHOSPHATE; LEPTIN; MESSENGER RNA; SODIUM MYOINOSITOL COTRANSPORTER 1; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; BONE MINERALIZATION; BONE REMODELING; BONE STRUCTURE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; EMBRYO; FEMALE; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KNOCKOUT MOUSE; MATERNAL CARE; MESENCHYME CELL; MICRO-COMPUTED TOMOGRAPHY; MOUSE; MOUSE EMBRYO; NONHUMAN; OSSIFICATION; OSTEOBLAST; PHENOTYPE; POSTNATAL DEVELOPMENT; PRENATAL DEVELOPMENT; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

AGING; ANIMALS; BONE AND BONES; CELL COUNT; CELL DIFFERENTIATION; CELL LINE; EMBRYO, MAMMALIAN; GENE DELETION; INOSITOL; INOSITOL 1,4,5-TRISPHOSPHATE; INTRACELLULAR SPACE; MESENCHYMAL STEM CELLS; MICE; ORGAN SIZE; OSTEOBLASTS; OSTEOGENESIS; OSTEOPOROSIS; SYMPORTERS; TRANSCRIPTION, GENETIC;

EID: 79951842355     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.240     Document Type: Article

References (41)

1. Downes CP, Macphee CH,. myo-Inositol metabolites as cellular signals. Eur J Biochem. 1990; 193: 1-18. (Pubitemid 20331603)
2. 1 adipocytes. Mol Cell Biol. 1997; 17: 190-198. (Pubitemid 26425608)
3. Wiese TJ, Dunlap JA, Conner CE, et al. Osmotic regulation of Na-myo-inositol cotransporter mRNA level and activity in endothelial and neural cells. Am J Physiol. 1996; 270 (4 pt 1): C990-997.
4. Schmolke M, Bornemann A, Guder WG,. Polyol determination along the rat nephron. Biol Chem Hoppe Seyler. 1990; 371: 909-916. (Pubitemid 20337928)
5. Fisher SK, Novak JE, Agranoff BW,. Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. J Neurochem. 2002; 82: 736-754.
6. Palatnik A, Frolov K, Fux M, Benjamin J,. Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder. J Clin Psychopharmacol. 2001; 21: 335-339. (Pubitemid 32452940)
7. Fux M, Levine J, Aviv A, Belmaker RH,. Inositol treatment of obsessive-compulsive disorder. Am J Psychiatry. 1996; 153: 1219-1221. (Pubitemid 26299846)
8. Taylor MJ, Wilder H, Bhagwagar Z, Geddes J,. Inositol for depressive disorders. Cochrane Database Syst Rev. 2004; (2): CD004049.
9. Johnson EC, Gray-Keller MP, O'Day PM,. Rescue of excitation by inositol following Li(+)-induced block in Limulus ventral photoreceptors. Vis Neurosci. 1998; 15: 105-112. (Pubitemid 128471562)
10. Vucenik I, Shamsuddin AM,. Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic. J Nutr. 2003; 133 (11 Suppl 1): 3778S-3784S. (Pubitemid 37392600)
11. Chen NX, et al. Ca(2+) regulates fluid shear-induced cytoskeletal reorganization and gene expression in osteoblasts. Am J Physiol Cell Physiol. 2000; 278: C989-997. (Pubitemid 30346935)
12. Ashizawa N, Yoshida M, Aotsuka T,. An enzymatic assay for myo-inositol in tissue samples. J Biochem Biophys Methods. 2000; 44: 89-94. (Pubitemid 30411938)
13. Biden TJ, Wollheim CB,. Active transport of myo-inositol in rat pancreatic islets. Biochem J. 1986; 236: 889-893. (Pubitemid 16067133)
14. Hager K, et al. Kinetics and specificity of the renal Na+/myo-inositol cotransporter expressed in Xenopus oocytes. J Membr Biol. 1995; 143: 103-113.
15. Chau JF, Lee MK, Law JW, Chung SK, Chung SS,. Sodium/myo-inositol cotransporter-1 is essential for the development and function of the peripheral nerves. FASEB J. 2005; 19: 1887-1889. (Pubitemid 41598784)
16. McLeod MJ,. Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S. Teratology. 1980; 22: 299-301. (Pubitemid 11209786)
17. Puchtler H, Waldrop FS, Valentine LS,. Polarization microscopic studies of connective tissue stained with picro-sirius red FBA. Beitr Pathol. 1973; 150: 174-187.
18. Miao D, Scutt A,. Recruitment, augmentation and apoptosis of rat osteoclasts in 1,25-(OH)2D3 response to short-term treatment with 1,25-dihydroxyvitamin D3 in vivo. BMC Musculoskelet Disord. 2002; 3: 16.
19. Miao D, et al. Osteomalacia in hyp mice is associated with abnormal phex expression and with altered bone matrix protein expression and deposition. Endocrinology. 2001; 142: 926-939. (Pubitemid 32222443)
20. Kondo H, et al. Total-body irradiation of postpubertal mice with (137)Cs acutely compromises the microarchitecture of cancellous bone and increases osteoclasts. Radiat Res. 2009; 171: 283-289.
21. Helfrich MH, Ralston SH, eds. Bone Research Protocols. Totowa, New Jersey: Humana Press, 2003: pp 21-22.
22. Augat P, Reeb H, Claes LE,. Prediction of fracture load at different skeletal sites by geometric properties of the cortical shell. J Bone Miner Res. 1996; 11: 1356-1363. (Pubitemid 26282537)
23. Berridge MJ,. Inositol trisphosphate and calcium signalling. Nature. 1993; 361: 315-325. (Pubitemid 23041621)
24. Ferris CD, Snyder SH,. IP3 receptors. Ligand-activated calcium channels in multiple forms. Adv Second Messenger Phosphoprotein Res. 1992; 26: 95-107.
25. Gardiner K, Slavov D, Bechtel L, Davisson M,. Annotation of human chromosome 21 for relevance to Down syndrome: gene structure and expression analysis. Genomics. 2002; 79: 833-843. (Pubitemid 34595318)
26. Berry GT, et al. Loss of murine Na+/myo-inositol cotransporter leads to brain myo-inositol depletion and central apnea. J Biol Chem. 2003; 278: 18297-18302. (Pubitemid 36799449)
27. Buccafusca R, et al. Characterization of the null murine sodium/myo-inositol cotransporter 1 (Smit1 or Slc5a3) phenotype: myo-inositol rescue is independent of expression of its cognate mitochondrial ribosomal protein subunit 6 (Mrps6) gene and of phosphatidylinositol levels in neonatal brain. Mol Genet Metab. 2008; 95: 81-95.
28. Bouxsein ML,. Bone quality: where do we go from here? Osteoporos Int. 2003; 14 (Suppl 5): S118-127.
29. Augat P, Schorlemmer S,. The role of cortical bone and its microstructure in bone strength. Age Ageing. 2006; 35 (Suppl 2): ii27-ii31. (Pubitemid 44687506)
30. Ducy P, et al. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 1999; 13: 1025-1036. (Pubitemid 29200985)
31. Otto F, et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 1997; 89: 765-771. (Pubitemid 27516179)
32. Koga T, et al. NFAT and Osterix cooperatively regulate bone formation. Nat Med. 2005; 11: 880-885. (Pubitemid 41161121)
33. Nakashima K, de Crombrugghe B,. Transcriptional mechanisms in osteoblast differentiation and bone formation. Trends Genet. 2003; 19: 458-466. (Pubitemid 36930029)
34. Streb H, Irvine RF, Berridge MJ, Schulz I,. Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature. 1983; 306: 67-69. (Pubitemid 13022768)
35. Sun X, et al. Conditional inactivation of Fgf4 reveals complexity of signalling during limb bud development. Nat Genet. 2000; 25: 83-86. (Pubitemid 30257042)
36. Kim HJ, Kim JH, Bae SC, Choi JY, Ryoo HM,. The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2. J Biol Chem. 2003; 278: 319-326.
37. Farre J, et al. FGF-4 increases in vitro expansion rate of human adult bone marrow-derived mesenchymal stem cells. Growth Factors. 2007; 25: 71-76. (Pubitemid 47487573)
38. Wlodarski K, Wlodarski P,. Leptin as a modulator of osteogenesis. Ortop Traumatol Rehabil. 2009; 11: 1-6.
39. Takayanagi H,. Osteoimmunology and the effects of the immune system on bone. Nat Rev Rheumatol. 2009; 5: 667-676.
40. Turner CH, Owan I, Jacob DS, McClintock R, Peacock M,. Effects of nitric oxide synthase inhibitors on bone formation in rats. Bone. 1997; 21: 487-490. (Pubitemid 28029690)
41. Watanuki M, et al. Role of inducible nitric oxide synthase in skeletal adaptation to acute increases in mechanical loading. J Bone Miner Res. 2002; 17: 1015-1025. (Pubitemid 34535139)